...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution- 2023-03-31
Reply New Message
Back To Forum List View

1) Hong Kong  $4,050,000.00  

(3M common shares@ $1.35 CAN) + ( half warrants @$1.35 expire 2023-11-14)

2) British Virgin Islands  $202,500.00 & 3) Alberta $40,500.00 (180K common shares in total @$1.35)
 
Total: $4,293,000.00 (CAN)


Koo
5 Recommendations
Re: Additional Exempt Distribution- 2023-03-31
1
Buckeyes
Apr 12, 2023 08:49AM
Re: Additional Exempt Distribution- 2023-03-31
1
KayakerBC
Apr 12, 2023 09:49AM
Re: Additional Exempt Distribution- 2023-03-31
4
KOO-KOO2
Apr 12, 2023 10:54AM
Re: Additional Exempt Distribution- 2023-03-31
3
KayakerBC
Apr 12, 2023 12:38PM
Icon president Re: Additional Exempt Distribution- 2023-03-31
4
Nextblockbuster
Apr 15, 2023 03:53PM
Re: Additional Exempt Distribution- 2023-03-31
1
KayakerBC
Apr 16, 2023 06:56PM
Icon president Re: Additional Exempt Distribution- 2023-03-31
4
Nextblockbuster
Apr 16, 2023 07:45PM
Re: Additional Exempt Distribution- 2023-03-31
3
tada
Apr 16, 2023 07:53PM
Icon president Re: Additional Exempt Distribution- 2023-03-31
2
Nextblockbuster
Apr 17, 2023 07:01AM
Icon president Re: Additional Exempt Distribution- 2023-03-31
5
RVXoldtimer
Apr 17, 2023 07:15PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply